Search results
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 5 days agoThe vaccine will be Moderna’s second product to enter the U.S. market after the FDA’s approval of...
Moderna wins second product approval with RSV vaccine
Market Watch· 6 days agoThe Food and Drug Administration approved the mRNA shot, mResvia, for adults 60 and older,...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 3 days agoCOVID vaccine, agency staff said in a briefing document released Monday. In the briefing document,...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 6 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
FDA Approves First mRNA RSV Vaccine
MedPage Today· 6 days agoThe vaccine will be Moderna's second marketed product, in addition to its SARS-CoV-2 mRNA-1273 vaccine (Spikevax).
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
ETF DAILY NEWS· 7 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...